Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects.
about
Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone massTroglitazone and Δ2Troglitazone enhance adiponectin expression in monocytes/macrophages through the AMP-activated protein kinase pathway.The Role of Sirtuins in Antioxidant and Redox Signaling.Expanded roles of the renin-angiotensin system.Telmisartan-induced PPARγ activity attenuates lipid accumulation in VSMCs via induction of autophagy.
P2860
Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Activation of AMPK-Sirt1 pathw ...... ink to anti-metabolic effects.
@en
Activation of AMPK-Sirt1 pathw ...... ink to anti-metabolic effects.
@nl
type
label
Activation of AMPK-Sirt1 pathw ...... ink to anti-metabolic effects.
@en
Activation of AMPK-Sirt1 pathw ...... ink to anti-metabolic effects.
@nl
prefLabel
Activation of AMPK-Sirt1 pathw ...... ink to anti-metabolic effects.
@en
Activation of AMPK-Sirt1 pathw ...... ink to anti-metabolic effects.
@nl
P2093
P1476
Activation of AMPK-Sirt1 pathw ...... ink to anti-metabolic effects.
@en
P2093
Asuka Shiota
Daiju Fukuda
Etsuko Uematsu
Hiroaki Masuzaki
Hiromi Sato
Hiroshi Sakaue
Hirotsugu Kurobe
Masataka Sata
Takeshi Soeki
Yoichiro Hirata
P356
10.1016/J.EJPHAR.2012.07.026
P407
P577
2012-07-20T00:00:00Z